imperatorin has been researched along with Pulmonary Arterial Remodeling in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, X; Wang, J; Yong, S; Zhang, P; Zhou, N | 1 |
| He, H; He, J; He, L; Song, J; Wang, T; Zhou, N | 1 |
2 other study(ies) available for imperatorin and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Imperatorin derivative OW1, a new vasoactive compound, attenuates cell proliferation and migration by inhibiting Nox1-mediated oxidative stress.
Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Mice; Myocytes, Smooth Muscle; NADPH Oxidase 1; NIH 3T3 Cells; Oxidative Stress; Rats; Reactive Oxygen Species; Vascular Remodeling | 2023 |
Antihypertensive and vascular remodelling effects of the imperatorin derivative OW1 in renovascular hypertension rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Calcitonin Gene-Related Peptide; Collagen Type I; Collagen Type III; Disease Models, Animal; Furocoumarins; Hypertension, Renovascular; Kidney; Male; Mesenteric Arteries; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Artery; Vascular Remodeling; Vasodilator Agents | 2014 |